PH25530A - Novle quinoline derivatives, processes for preparation thereof, antibacterial agent containing them - Google Patents
Novle quinoline derivatives, processes for preparation thereof, antibacterial agent containing themInfo
- Publication number
- PH25530A PH25530A PH37684A PH37684A PH25530A PH 25530 A PH25530 A PH 25530A PH 37684 A PH37684 A PH 37684A PH 37684 A PH37684 A PH 37684A PH 25530 A PH25530 A PH 25530A
- Authority
- PH
- Philippines
- Prior art keywords
- novle
- processes
- preparation
- antibacterial agent
- agent containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26244187 | 1987-10-16 | ||
| JP10884088 | 1988-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH25530A true PH25530A (en) | 1991-07-24 |
Family
ID=26448650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH37684A PH25530A (en) | 1987-10-16 | 1988-10-14 | Novle quinoline derivatives, processes for preparation thereof, antibacterial agent containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5013841A (zh) |
| EP (1) | EP0312085B1 (zh) |
| KR (1) | KR930006774B1 (zh) |
| CN (1) | CN1021967C (zh) |
| DE (1) | DE3880953T2 (zh) |
| DK (1) | DK573788A (zh) |
| ES (1) | ES2054762T3 (zh) |
| FI (1) | FI884752A (zh) |
| HU (1) | HU204521B (zh) |
| IL (1) | IL88003A (zh) |
| NO (1) | NO171016C (zh) |
| NZ (1) | NZ226574A (zh) |
| PH (1) | PH25530A (zh) |
| PT (1) | PT88769A (zh) |
| RU (2) | RU1780534C (zh) |
| YU (3) | YU46647B (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
| ES2147721T3 (es) | 1990-04-18 | 2000-10-01 | Procter & Gamble Pharma | Quinolonil lactamas antimicrobianas. |
| DE4019023A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
| TW252107B (zh) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| FR2916446B1 (fr) * | 2007-05-24 | 2009-08-21 | Biocodex Sa | Nouveau procede de synthese de fluoroquinolones |
| WO2019148291A1 (en) | 2018-02-02 | 2019-08-08 | Interface Biologics, Inc. | Ocular inserts comprising a covalently linked steroid dimer |
| WO2021220061A2 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| DE3248506A1 (de) * | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
| DE3542002A1 (de) * | 1985-11-28 | 1987-06-04 | Bayer Ag | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| US4668680A (en) * | 1985-12-12 | 1987-05-26 | Warner-Lambert Company | 5-amino-6,8-difluoroquinolones as antibacterial agents |
| JPS62215572A (ja) * | 1986-03-17 | 1987-09-22 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
| DE3711193A1 (de) * | 1987-04-02 | 1988-10-13 | Bayer Ag | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
| US5591744A (en) * | 1987-04-16 | 1997-01-07 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-10-11 IL IL88003A patent/IL88003A/xx unknown
- 1988-10-14 ES ES88117113T patent/ES2054762T3/es not_active Expired - Lifetime
- 1988-10-14 EP EP88117113A patent/EP0312085B1/en not_active Expired - Lifetime
- 1988-10-14 PT PT88769A patent/PT88769A/pt unknown
- 1988-10-14 DK DK573788A patent/DK573788A/da not_active Application Discontinuation
- 1988-10-14 YU YU192288A patent/YU46647B/sh unknown
- 1988-10-14 DE DE88117113T patent/DE3880953T2/de not_active Expired - Fee Related
- 1988-10-14 NO NO884599A patent/NO171016C/no unknown
- 1988-10-14 FI FI884752A patent/FI884752A/fi not_active Application Discontinuation
- 1988-10-14 HU HU885296A patent/HU204521B/hu not_active IP Right Cessation
- 1988-10-14 PH PH37684A patent/PH25530A/en unknown
- 1988-10-14 NZ NZ226574A patent/NZ226574A/en unknown
- 1988-10-15 KR KR1019880013470A patent/KR930006774B1/ko active IP Right Grant
- 1988-10-15 CN CN88108434A patent/CN1021967C/zh not_active Expired - Fee Related
-
1989
- 1989-08-04 US US07/389,900 patent/US5013841A/en not_active Expired - Fee Related
- 1989-10-13 YU YU199089A patent/YU46703B/sh unknown
- 1989-10-13 YU YU198989A patent/YU46684B/sh unknown
- 1989-10-18 RU SU894742183A patent/RU1780534C/ru active
- 1989-10-20 RU SU894742186A patent/RU1830067C/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| YU46684B (sh) | 1994-04-05 |
| NZ226574A (en) | 1991-07-26 |
| DE3880953T2 (de) | 1993-10-14 |
| KR930006774B1 (ko) | 1993-07-23 |
| FI884752A (fi) | 1989-04-17 |
| CN1033996A (zh) | 1989-07-19 |
| NO884599D0 (no) | 1988-10-14 |
| FI884752A0 (fi) | 1988-10-14 |
| RU1780534C (ru) | 1992-12-07 |
| EP0312085A3 (en) | 1990-05-30 |
| EP0312085B1 (en) | 1993-05-12 |
| YU198989A (en) | 1990-04-30 |
| HUT49342A (en) | 1989-09-28 |
| AU2375488A (en) | 1989-04-20 |
| CN1021967C (zh) | 1993-09-01 |
| AU619214B2 (en) | 1992-01-23 |
| KR890006620A (ko) | 1989-06-14 |
| YU46703B (sh) | 1994-04-05 |
| PT88769A (pt) | 1989-07-31 |
| NO171016B (no) | 1992-10-05 |
| DE3880953D1 (de) | 1993-06-17 |
| NO884599L (no) | 1989-04-17 |
| HU204521B (en) | 1992-01-28 |
| EP0312085A2 (en) | 1989-04-19 |
| DK573788A (da) | 1989-04-17 |
| ES2054762T3 (es) | 1994-08-16 |
| IL88003A (en) | 1992-11-15 |
| DK573788D0 (da) | 1988-10-14 |
| YU192288A (en) | 1990-04-30 |
| YU46647B (sh) | 1994-01-20 |
| YU199089A (en) | 1990-04-30 |
| IL88003A0 (en) | 1989-06-30 |
| RU1830067C (ru) | 1993-07-23 |
| US5013841A (en) | 1991-05-07 |
| NO171016C (no) | 1993-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3465989D1 (en) | 7-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, processes for their preparation and antibacterial agents containing them | |
| EP0412848A3 (en) | Quinoline derivatives, process for their preparation and their use as medicaments | |
| PT80578A (en) | Process for preparing 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and antibacterial agents containing them | |
| ZA816080B (en) | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids,processes for their preparation and antibacterial agents containing these compounds | |
| IL87809A0 (en) | Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL87731A (en) | Cephem derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA841375B (en) | Quinolone acids,processes for their preparation and antibacterial agents containing these compounds | |
| EP0435333A3 (en) | Cephalosporin derivatives, the process for preparing the same, and antimicrobial composition containing the derivatives | |
| HUT42082A (en) | Process for preparing quinolone derivatives | |
| EP0238060A3 (en) | Cephalosporin derivatives, processes for their preparation and antibacterial agents | |
| AU2197688A (en) | New compounds, processes for their preparation and use thereof | |
| PH25530A (en) | Novle quinoline derivatives, processes for preparation thereof, antibacterial agent containing them | |
| IL87563A (en) | Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| EP0441036A3 (en) | Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives | |
| AU1630188A (en) | Substituted compounds, processes for their preparation and their use as medicaments | |
| EP0472826A3 (en) | Novel quinolinecarboxylic acid derivatives, use thereof, antibacterial agent containing the same, process for preparing said compounds and intermediate compound | |
| AU2676688A (en) | 6-fluoro-5-methyl-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives | |
| EP0282895A3 (en) | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | |
| IL74499A0 (en) | Cephalosporin derivatives,processes for the preparation thereof,and antibacterial compositions containing the same | |
| ZA889188B (en) | Novel quinoline derivatives,processes for preparation thereof and antibacterial agent containing them | |
| ZA887678B (en) | Novel quinoline derivatives,processes for preparation thereof and antibacterial agent containing them | |
| EP0301245A3 (en) | 3-sulfonyl-3,7-diazabicyclo-(3,3,1)nonane compounds, processes for their preparation, and medicaments containing these compounds | |
| GB2171991B (en) | Novel macrolide derivatives, process for preparing same, and antibacterial compositions thereof | |
| AU619214C (en) | Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them | |
| GB2234748B (en) | Quinoline derivatives, process for their preparation and their use as medicaments |